Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

More articles from Letter to the Editor

  • You have access
    Regulatory Recommendations for Calculating the Unbound Maximum Hepatic Inlet Concentration: A Complicated Story with a Surprising and Happy Ending
    Andrew Parkinson
    Drug Metabolism and Disposition July 2019, 47 (7) 779-784; DOI: https://doi.org/10.1124/dmd.119.086496
  • You have access
    Misidentification of Bupropion Glucuronide Metabolites and Re-evaluation of Metabolite Pharmacokinetics
    Aaron M. Teitelbaum and Evan D. Kharasch
    Drug Metabolism and Disposition November 2016, 44 (11) 1851; DOI: https://doi.org/10.1124/dmd.116.072892
  • You have access
    Response to Letter to the Editor on “Fractional Clearance for Verapamil N-Demethylation in the Isolated Rat Liver Preparation”
    K. Sandy Pang and Qi Joy Yang
    Drug Metabolism and Disposition July 2015, 43 (7) 1058-1059; DOI: https://doi.org/10.1124/dmd.115.065227
  • You have access
    Fractional Clearance for Verapamil N-Demethylation in the Isolated Rat Liver Preparation
    Reza Mehvar
    Drug Metabolism and Disposition July 2015, 43 (7) 1056-1057; DOI: https://doi.org/10.1124/dmd.115.064691
  • You have access
    Clinical Relevance of CYP3A5 Genotype on Maraviroc Exposures
    Manoli Vourvahis, Lynn McFadyen, Jayvant Heera and Andrew Clark
    Drug Metabolism and Disposition May 2015, 43 (5) 771-772; DOI: https://doi.org/10.1124/dmd.115.063321
  • You have access
    Response to “Clinical Relevance of CYP3A5 Genotype on Maraviroc Exposures”
    Yanhui Lu, Edward J. Fuchs, Craig W. Hendrix and Namandjé N. Bumpus
    Drug Metabolism and Disposition May 2015, 43 (5) 773; DOI: https://doi.org/10.1124/dmd.115.064188
  • You have access
    Response to “Breast Cancer Resistance Protein Substrate and Inhibition Evaluation: Why, When, and How?”
    Agnès Poirier, Mohammed Ullah and Christoph Funk
    Drug Metabolism and Disposition December 2014, 42 (12) 1981; DOI: https://doi.org/10.1124/dmd.114.061465
  • You have access
    Breast Cancer Resistance Protein Substrate and Inhibition Evaluation: Why, When, and How?
    Joseph A. Ware, Bradley L. Urquhart, Yuichi Sugiyama and Maciej J. Zamek-Gliszczynski
    Drug Metabolism and Disposition December 2014, 42 (12) 1979-1980; DOI: https://doi.org/10.1124/dmd.114.060970
  • You have access
    Lack of In Vitro–In Vivo Correlation of Adulthood Cytochrome P450 Activities in Low-Birth-Weight Rats
    Ganesh Cherala, Jacob Pearson, Barent DuBois and Tahir Mahmood
    Drug Metabolism and Disposition March 2014, 42 (3) 481; DOI: https://doi.org/10.1124/dmd.113.056721
  • You have access
    Endogenous 4β-Hydroxycholesterol-to-Cholesterol Ratio Is Not a Validated Biomarker for the Assessment of CYP3A Activity
    Joseph D. Ma, Anne N. Nafziger and Joseph S. Bertino
    Drug Metabolism and Disposition November 2013, 41 (11) 1972; DOI: https://doi.org/10.1124/dmd.113.054361

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics